MedTrace Logo

Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus

NCT00145093 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2005-11-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether chromium (yeast), is effective in improving glycaemic control and insulin resistance.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Baker's yeast (Bio Chromium)

Sponsors & Collaborators

  • Pharma Nord

    collaborator INDUSTRY

  • Medical Research Foundation, The Netherlands

    lead OTHER

Principal Investigators

  • Henk JG Bilo, MD PhD FRCP · Isala clinics, medical research foundation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Completion
2005-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00145093 on ClinicalTrials.gov